_id
69147bb3ccc777a4e85d909f
Ticker
MRES
Name
Institute of Biomedical Research Corp
Exchange
PINK
Address
Ljubljanska bb, Podgorica, Montenegro, 81000
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://mrescorp.com
Description
Institute of Biomedical Research Corp. provides biomedical research and analytical services in Montenegro and internationally. Its services include regulatory control of industrial activities and products; scientific surveillance of the living environment; research and development of biomedical products and technologies; regulatory evaluation and certification of biomedical products; fundamental scientific research; and development of new diagnostic methods and experimental medical treatments. The company also researchers and develops new biomedical and food products; provides programs for graduate research studies in biomedical and environmental fields; offers two channel analog NMS, digital muscle stimulator, digital TENS, interferential, elite combination, portable four channel digital, portable ultra sound, and other healthcare devices; and provides photon red light for beauty, electric pain relief products, microcurrent electrical nerve stimulators, and high volt pulsed stimulators. In addition, it develops and commercializes microbicidal agents; disinfectant products; bandages for large burns, hard surface disinfection, microbicidal treatment of fabrics and textile products, insecticides against bed bugs and other textile goods, microbicidal towels, and mouthwash products; Purilair, an appliance that sterilizes compressed air circulating within medical instruments; colloidal silver and electro medical devices; and BioStim INF that is used for edema reduction, pain relief, and total treatment. Further, the company provides quality control, regulatory, healthcare, environmental services, environmental analysis, building decontamination, and environmental protection and management services; and regulatory certifications of new biomedical products. Institute of Biomedical Research Corp. was founded in 2010 and is based in Podgorica, Montenegro with a representative office in Montreal, Canada.
Last Close
0.0028
Volume
166803
Current Price
0.0069
Change
52
Last Updated
2026-01-05T10:50:08.844Z
Image
-
Ipo Date
-
Market Cap
7572564
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-03-31
Revenue
19256
Cost Of Revenue
10128
Gross Profit
9128
Operating Expenses
299881
Operating Income
-290753
Interest Expense
4139
Pretax Income
-300280
Net Income
-145143
Eps
-0.00005449105042416261
Dividends Per Share
-
Shares Outstanding
2704487420
Income Tax Expense
-
EBITDA
-302243
Operating Margin
-1509.9345658496054
Total Other Income Expense Net
-9527
Cash
11804
Short Term Investments
-
Receivables
36269
Inventories
18791
Total Current Assets
108269
Property Plant Equipment
5625
Total Assets
3313582
Payables
-
Short Term Debt
-
Long Term Debt
-
Total Liabilities
775716
Equity
583870
Bs_currency_symbol
-
Depreciation
-
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
-
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
Cf_currency_symbol
-
PE
-
PB
31.47776182883176
ROE
-24.85878705876308
ROA
-4.3802447019569755
FCF
-
Fcf Percent
-
Piotroski FScore
0
Health Score
24
Deep Value Investing Score
1.5
Defensive Investing Score
4
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
3.5
Growth Investing Score
3.5
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
1.5
Value Investing Score
2
Quarters > 0 > quarter
2025-03-31
Quarters > 0 > income Statement > revenue
19256
Quarters > 0 > income Statement > cost Of Revenue
10128
Quarters > 0 > income Statement > gross Profit
9128
Quarters > 0 > income Statement > operating Expenses
299881
Quarters > 0 > income Statement > operating Income
-290753
Quarters > 0 > income Statement > interest Expense
4139
Quarters > 0 > income Statement > pretax Income
-300280
Quarters > 0 > income Statement > net Income
-145143
Quarters > 0 > income Statement > eps
-0.00005449105042416261
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
2663611710
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-302243
Quarters > 0 > income Statement > operating Margin
-1509.9345658496054
Quarters > 0 > income Statement > total Other Income Expense Net
-9527
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
11804
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
36269
Quarters > 0 > balance Sheet > inventories
18791
Quarters > 0 > balance Sheet > total Current Assets
108269
Quarters > 0 > balance Sheet > property Plant Equipment
5625
Quarters > 0 > balance Sheet > total Assets
3313582
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
775716
Quarters > 0 > balance Sheet > equity
583870
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
-
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.00005449105042416261
Quarters > 0 > ratios > PB
31.47776182883176
Quarters > 0 > ratios > ROE
-24.85878705876308
Quarters > 0 > ratios > ROA
-4.3802447019569755
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
24
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
9333
Quarters > 1 > income Statement > cost Of Revenue
7266
Quarters > 1 > income Statement > gross Profit
2067
Quarters > 1 > income Statement > operating Expenses
-146352
Quarters > 1 > income Statement > operating Income
148419
Quarters > 1 > income Statement > interest Expense
3827
Quarters > 1 > income Statement > pretax Income
135830
Quarters > 1 > income Statement > net Income
158526
Quarters > 1 > income Statement > eps
0.00006684843893210425
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
2371424113
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
139656
Quarters > 1 > income Statement > operating Margin
1590.2603664416586
Quarters > 1 > income Statement > total Other Income Expense Net
-12589
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
317
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
29306
Quarters > 1 > balance Sheet > inventories
20957
Quarters > 1 > balance Sheet > total Current Assets
127874
Quarters > 1 > balance Sheet > property Plant Equipment
6703
Quarters > 1 > balance Sheet > total Assets
3194329
Quarters > 1 > balance Sheet > payables
-
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
799795
Quarters > 1 > balance Sheet > equity
1208658
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-
Quarters > 1 > cash Flow > capital Expenditures
-
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
0.00006684843893210425
Quarters > 1 > ratios > PB
13.538011893935256
Quarters > 1 > ratios > ROE
13.115869005128001
Quarters > 1 > ratios > ROA
4.9627323923115
Quarters > 1 > ratios > FCF
-
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
60
Quarters > 2 > quarter
2024-09-30
Quarters > 2 > income Statement > revenue
7722
Quarters > 2 > income Statement > cost Of Revenue
4957
Quarters > 2 > income Statement > gross Profit
2765
Quarters > 2 > income Statement > operating Expenses
252709
Quarters > 2 > income Statement > operating Income
-249944
Quarters > 2 > income Statement > interest Expense
3747
Quarters > 2 > income Statement > pretax Income
-169035
Quarters > 2 > income Statement > net Income
-195881
Quarters > 2 > income Statement > eps
-0.00008260057698080766
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
2371424113
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-165288
Quarters > 2 > income Statement > operating Margin
-3236.778036778037
Quarters > 2 > income Statement > total Other Income Expense Net
80909
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
5920
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
35909
Quarters > 2 > balance Sheet > inventories
22666
Quarters > 2 > balance Sheet > total Current Assets
176884
Quarters > 2 > balance Sheet > property Plant Equipment
8710
Quarters > 2 > balance Sheet > total Assets
3257006
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1067865
Quarters > 2 > balance Sheet > equity
256367
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-
Quarters > 2 > cash Flow > capital Expenditures
-
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.00008260057698080766
Quarters > 2 > ratios > PB
63.825790291652204
Quarters > 2 > ratios > ROE
-76.40647977313773
Quarters > 2 > ratios > ROA
-6.014143050396592
Quarters > 2 > ratios > FCF
-
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
16
Quarters > 3 > quarter
2024-06-30
Quarters > 3 > income Statement > revenue
13176
Quarters > 3 > income Statement > cost Of Revenue
5734
Quarters > 3 > income Statement > gross Profit
7441
Quarters > 3 > income Statement > operating Expenses
371677
Quarters > 3 > income Statement > operating Income
-364235
Quarters > 3 > income Statement > interest Expense
3669
Quarters > 3 > income Statement > pretax Income
-406155
Quarters > 3 > income Statement > net Income
-450222
Quarters > 3 > income Statement > eps
-0.00018985300753750073
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
2371424113
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-402485
Quarters > 3 > income Statement > operating Margin
-2764.3822100789316
Quarters > 3 > income Statement > total Other Income Expense Net
-41920
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
1101
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
47272
Quarters > 3 > balance Sheet > inventories
26148
Quarters > 3 > balance Sheet > total Current Assets
221161
Quarters > 3 > balance Sheet > property Plant Equipment
9831
Quarters > 3 > balance Sheet > total Assets
3296742
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1051539
Quarters > 3 > balance Sheet > equity
1152411
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-
Quarters > 3 > cash Flow > depreciation
-
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-
Quarters > 3 > cash Flow > capital Expenditures
-
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.00018985300753750073
Quarters > 3 > ratios > PB
14.198776634117515
Quarters > 3 > ratios > ROE
-39.06783257015075
Quarters > 3 > ratios > ROA
-13.656573671825093
Quarters > 3 > ratios > FCF
-
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
30
Annuals > 0 > quarter
2025-03-31
Annuals > 0 > income Statement > revenue
49487
Annuals > 0 > income Statement > cost Of Revenue
28085
Annuals > 0 > income Statement > gross Profit
21402
Annuals > 0 > income Statement > operating Expenses
777915
Annuals > 0 > income Statement > operating Income
-756513
Annuals > 0 > income Statement > interest Expense
15382
Annuals > 0 > income Statement > pretax Income
-739640
Annuals > 0 > income Statement > net Income
-632720
Annuals > 0 > income Statement > eps
-0.0002375421303430146
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
2663611710
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-724260
Annuals > 0 > income Statement > operating Margin
-1528.7105704528462
Annuals > 0 > income Statement > total Other Income Expense Net
16873
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
11804
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
36269
Annuals > 0 > balance Sheet > inventories
18791
Annuals > 0 > balance Sheet > total Current Assets
108269
Annuals > 0 > balance Sheet > property Plant Equipment
5625
Annuals > 0 > balance Sheet > total Assets
3313582
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
775716
Annuals > 0 > balance Sheet > equity
583870
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-
Annuals > 0 > cash Flow > depreciation
-
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-
Annuals > 0 > cash Flow > capital Expenditures
-
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-
Annuals > 0 > cash Flow > net Change In Cash
-
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-0.0002375421303430146
Annuals > 0 > ratios > PB
12.773584510250569
Annuals > 0 > ratios > ROE
-108.36658845290903
Annuals > 0 > ratios > ROA
-19.09474399607434
Annuals > 0 > ratios > FCF
-
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
24
Annuals > 1 > quarter
2024-03-31
Annuals > 1 > income Statement > revenue
45074
Annuals > 1 > income Statement > cost Of Revenue
36525
Annuals > 1 > income Statement > gross Profit
8549
Annuals > 1 > income Statement > operating Expenses
1804746
Annuals > 1 > income Statement > operating Income
-1796197
Annuals > 1 > income Statement > interest Expense
36633
Annuals > 1 > income Statement > pretax Income
1356773
Annuals > 1 > income Statement > net Income
1329831
Annuals > 1 > income Statement > eps
0.0005607731627210624
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
2371424113
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
1393407
Annuals > 1 > income Statement > operating Margin
-3984.995784709589
Annuals > 1 > income Statement > total Other Income Expense Net
3152970
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
99418
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
35909
Annuals > 1 > balance Sheet > inventories
29744
Annuals > 1 > balance Sheet > total Current Assets
323312
Annuals > 1 > balance Sheet > property Plant Equipment
10855
Annuals > 1 > balance Sheet > total Assets
3487567
Annuals > 1 > balance Sheet > payables
-
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
935306
Annuals > 1 > balance Sheet > equity
1483654
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
-
Annuals > 1 > cash Flow > depreciation
-
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
-
Annuals > 1 > cash Flow > capital Expenditures
-
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-
Annuals > 1 > cash Flow > net Change In Cash
-
Annuals > 1 > cash Flow > currency_symbol
-
Annuals > 1 > ratios > PE
0.0005607731627210624
Annuals > 1 > ratios > PB
4.475428581326914
Annuals > 1 > ratios > ROE
89.63215143153323
Annuals > 1 > ratios > ROA
38.130622293421176
Annuals > 1 > ratios > FCF
-
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
73
Annuals > 2 > quarter
2023-03-31
Annuals > 2 > income Statement > revenue
29444
Annuals > 2 > income Statement > cost Of Revenue
20770
Annuals > 2 > income Statement > gross Profit
8674
Annuals > 2 > income Statement > operating Expenses
732549
Annuals > 2 > income Statement > operating Income
-723875
Annuals > 2 > income Statement > interest Expense
49309
Annuals > 2 > income Statement > pretax Income
-433406
Annuals > 2 > income Statement > net Income
-433406
Annuals > 2 > income Statement > eps
-0.00029794677278790745
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
1454642371
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-384102
Annuals > 2 > income Statement > operating Margin
-2458.480505366119
Annuals > 2 > income Statement > total Other Income Expense Net
290469
Annuals > 2 > income Statement > currency_symbol
-
Annuals > 2 > balance Sheet > cash
5196
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
68459
Annuals > 2 > balance Sheet > inventories
5403
Annuals > 2 > balance Sheet > total Current Assets
216658
Annuals > 2 > balance Sheet > property Plant Equipment
14509
Annuals > 2 > balance Sheet > total Assets
637937
Annuals > 2 > balance Sheet > payables
-
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
759148
Annuals > 2 > balance Sheet > equity
-121211
Annuals > 2 > balance Sheet > currency_symbol
-
Annuals > 2 > cash Flow > net Income
-
Annuals > 2 > cash Flow > depreciation
-
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
-
Annuals > 2 > cash Flow > capital Expenditures
-
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
-
Annuals > 2 > cash Flow > net Change In Cash
-
Annuals > 2 > cash Flow > currency_symbol
-
Annuals > 2 > ratios > PE
-0.00029794677278790745
Annuals > 2 > ratios > PB
-33.60254959368374
Annuals > 2 > ratios > ROE
357.5632574601315
Annuals > 2 > ratios > ROA
-67.93868360041823
Annuals > 2 > ratios > FCF
-
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
38
Annuals > 3 > quarter
2022-03-31
Annuals > 3 > income Statement > revenue
-
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
167005
Annuals > 3 > income Statement > operating Income
-167005
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-167005
Annuals > 3 > income Statement > net Income
-167005
Annuals > 3 > income Statement > eps
-0.00018236186836733024
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
915789038
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-167005
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > income Statement > currency_symbol
-
Annuals > 3 > balance Sheet > cash
-
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
-
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
-
Annuals > 3 > balance Sheet > payables
-
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
-
Annuals > 3 > balance Sheet > equity
-
Annuals > 3 > balance Sheet > currency_symbol
-
Annuals > 3 > cash Flow > net Income
-
Annuals > 3 > cash Flow > depreciation
-
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
-
Annuals > 3 > cash Flow > capital Expenditures
-
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
-
Annuals > 3 > cash Flow > net Change In Cash
-
Annuals > 3 > cash Flow > currency_symbol
-
Annuals > 3 > ratios > PE
-0.00018236186836733024
Annuals > 3 > ratios > PB
-
Annuals > 3 > ratios > ROE
-
Annuals > 3 > ratios > ROA
-
Annuals > 3 > ratios > FCF
-
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
39
Valuation > metrics > PE
-0.00005449105042416261
Valuation > metrics > PB
31.47776182883176
Valuation > final Score
20
Valuation > verdict
949.3% Overvalued
Profitability > metrics > ROE
-24.85878705876308
Profitability > metrics > ROA
-134.0577635334214
Profitability > metrics > Net Margin
-7.537546738678853
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.3285765667014917
Risk > metrics > Interest Coverage
-70.24716115003623
Risk > final Score
-251
Risk > verdict
High
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
40
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
86
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
88
Prev Risks > 1
-261
Prev Risks > 2
-349
Prev Liquidities > 0
50
Prev Liquidities > 1
50
Prev Liquidities > 2
50
Updated At
2026-01-20T22:14:13.936Z
Earnings History > 0 > period
2025-03-31
Earnings History > 0 > report Date
2025-03-31
Earnings History > 0 > date
2025-03-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.0001
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2024-12-31
Earnings History > 1 > report Date
2024-12-31
Earnings History > 1 > date
2024-12-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.0001
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-09-30
Earnings History > 2 > report Date
2024-09-30
Earnings History > 2 > date
2024-09-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.0001
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-06-30
Earnings History > 3 > report Date
2024-06-30
Earnings History > 3 > date
2024-06-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.0002
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-03-31
Earnings History > 4 > report Date
2024-03-31
Earnings History > 4 > date
2024-03-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
0.0007
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2023-12-31
Earnings History > 5 > report Date
2023-12-31
Earnings History > 5 > date
2023-12-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
0.0002
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2023-09-30
Earnings History > 6 > report Date
2023-09-30
Earnings History > 6 > date
2023-09-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
-0.0001
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-06-30
Earnings History > 7 > report Date
2023-06-30
Earnings History > 7 > date
2023-06-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
-0.0002
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-03-31
Earnings History > 8 > report Date
2023-03-31
Earnings History > 8 > date
2023-03-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
0.0001
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2022-12-31
Earnings History > 9 > report Date
2022-12-31
Earnings History > 9 > date
2022-12-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
-0.0003
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2022-09-30
Earnings History > 10 > report Date
2022-09-30
Earnings History > 10 > date
2022-09-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
-
Earnings History > 10 > eps Actual
-0.0002
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-06-30
Earnings History > 11 > report Date
2022-06-30
Earnings History > 11 > date
2022-06-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
-
Earnings History > 11 > eps Actual
0
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-03-31
Earnings History > 12 > report Date
2022-03-31
Earnings History > 12 > date
2022-03-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
-
Earnings History > 12 > eps Actual
-0.0001
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2021-12-31
Earnings History > 13 > report Date
2021-12-31
Earnings History > 13 > date
2021-12-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
-
Earnings History > 13 > eps Actual
-0.0001
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2021-09-30
Earnings History > 14 > report Date
2021-09-30
Earnings History > 14 > date
2021-09-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
-
Earnings History > 14 > eps Actual
-0.0001
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-06-30
Earnings History > 15 > report Date
2021-06-30
Earnings History > 15 > date
2021-06-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
-
Earnings History > 15 > eps Actual
0
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-03-31
Earnings History > 16 > report Date
2021-03-31
Earnings History > 16 > date
2021-03-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
-
Earnings History > 16 > eps Actual
0
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2020-12-31
Earnings History > 17 > report Date
2020-12-31
Earnings History > 17 > date
2020-12-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
0
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2020-09-30
Earnings History > 18 > report Date
2020-09-30
Earnings History > 18 > date
2020-09-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
0
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-06-30
Earnings History > 19 > report Date
2020-06-30
Earnings History > 19 > date
2020-06-30
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
0
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-03-31
Earnings History > 20 > report Date
2020-03-31
Earnings History > 20 > date
2020-03-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
0
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2019-12-31
Earnings History > 21 > report Date
2019-12-31
Earnings History > 21 > date
2019-12-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
0
Earnings History > 21 > eps Estimate
-
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2019-09-30
Earnings History > 22 > report Date
2019-09-30
Earnings History > 22 > date
2019-09-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
0
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2019-06-30
Earnings History > 23 > report Date
2019-06-30
Earnings History > 23 > date
2019-06-30
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
0
Earnings History > 23 > eps Estimate
-
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2019-03-31
Earnings History > 24 > report Date
2019-03-31
Earnings History > 24 > date
2019-03-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
0
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2018-12-31
Earnings History > 25 > report Date
2018-12-31
Earnings History > 25 > date
2018-12-31
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
0
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2018-09-30
Earnings History > 26 > report Date
2018-09-30
Earnings History > 26 > date
2018-09-30
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
0
Earnings History > 26 > eps Estimate
-
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2018-06-30
Earnings History > 27 > report Date
2018-06-30
Earnings History > 27 > date
2018-06-30
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
0
Earnings History > 27 > eps Estimate
-
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2015-06-30
Earnings History > 28 > report Date
2015-06-30
Earnings History > 28 > date
2015-06-30
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
0.0002
Earnings History > 28 > eps Estimate
-
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2015-03-31
Earnings History > 29 > report Date
2015-03-31
Earnings History > 29 > date
2015-03-31
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
0.0002
Earnings History > 29 > eps Estimate
-
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2014-12-31
Earnings History > 30 > report Date
2014-12-31
Earnings History > 30 > date
2014-12-31
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
0.0002
Earnings History > 30 > eps Estimate
-
Earnings History > 30 > eps Difference
0
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2014-09-30
Earnings History > 31 > report Date
2014-09-30
Earnings History > 31 > date
2014-09-30
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
0.0001
Earnings History > 31 > eps Estimate
-
Earnings History > 31 > eps Difference
0
Earnings History > 31 > surprise Percent
-
Earnings History > 32 > period
2014-06-30
Earnings History > 32 > report Date
2014-06-30
Earnings History > 32 > date
2014-06-30
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
0.0001
Earnings History > 32 > eps Estimate
-
Earnings History > 32 > eps Difference
0
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2014-03-31
Earnings History > 33 > report Date
2014-03-31
Earnings History > 33 > date
2014-03-31
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
0.0012
Earnings History > 33 > eps Estimate
-
Earnings History > 33 > eps Difference
0
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2013-12-31
Earnings History > 34 > report Date
2013-12-31
Earnings History > 34 > date
2013-12-31
Earnings History > 34 > before After Market
-
Earnings History > 34 > currency
USD
Earnings History > 34 > eps Actual
-0.0001
Earnings History > 34 > eps Estimate
-
Earnings History > 34 > eps Difference
0
Earnings History > 34 > surprise Percent
-
Earnings History > 35 > period
2010-12-31
Earnings History > 35 > report Date
2010-12-31
Earnings History > 35 > date
2010-12-31
Earnings History > 35 > before After Market
-
Earnings History > 35 > currency
USD
Earnings History > 35 > eps Actual
-0.0008
Earnings History > 35 > eps Estimate
-
Earnings History > 35 > eps Difference
0
Earnings History > 35 > surprise Percent
-
Earnings History > 36 > period
2010-09-30
Earnings History > 36 > report Date
2010-09-30
Earnings History > 36 > date
2010-09-30
Earnings History > 36 > before After Market
-
Earnings History > 36 > currency
USD
Earnings History > 36 > eps Actual
-0.0012
Earnings History > 36 > eps Estimate
-
Earnings History > 36 > eps Difference
0
Earnings History > 36 > surprise Percent
-
Earnings History > 37 > period
2010-06-30
Earnings History > 37 > report Date
2010-06-30
Earnings History > 37 > date
2010-06-30
Earnings History > 37 > before After Market
-
Earnings History > 37 > currency
USD
Earnings History > 37 > eps Actual
-1.0516
Earnings History > 37 > eps Estimate
-
Earnings History > 37 > eps Difference
0
Earnings History > 37 > surprise Percent
-
Earnings History > 38 > period
2010-03-31
Earnings History > 38 > report Date
2010-03-31
Earnings History > 38 > date
2010-03-31
Earnings History > 38 > before After Market
-
Earnings History > 38 > currency
USD
Earnings History > 38 > eps Actual
-0.0223
Earnings History > 38 > eps Estimate
-
Earnings History > 38 > eps Difference
0
Earnings History > 38 > surprise Percent
-
Earnings History > 39 > period
2009-12-31
Earnings History > 39 > report Date
2009-12-31
Earnings History > 39 > date
2009-12-31
Earnings History > 39 > before After Market
-
Earnings History > 39 > currency
USD
Earnings History > 39 > eps Actual
-0.0189
Earnings History > 39 > eps Estimate
-
Earnings History > 39 > eps Difference
0
Earnings History > 39 > surprise Percent
-
Earnings History > 40 > period
2009-09-30
Earnings History > 40 > report Date
2009-09-30
Earnings History > 40 > date
2009-09-30
Earnings History > 40 > before After Market
-
Earnings History > 40 > currency
USD
Earnings History > 40 > eps Actual
-0.0039
Earnings History > 40 > eps Estimate
-
Earnings History > 40 > eps Difference
0
Earnings History > 40 > surprise Percent
-
Earnings History > 41 > period
2009-06-30
Earnings History > 41 > report Date
2009-06-30
Earnings History > 41 > date
2009-06-30
Earnings History > 41 > before After Market
-
Earnings History > 41 > currency
USD
Earnings History > 41 > eps Actual
-0.0059
Earnings History > 41 > eps Estimate
-
Earnings History > 41 > eps Difference
0
Earnings History > 41 > surprise Percent
-
Earnings History > 42 > period
2009-03-31
Earnings History > 42 > report Date
2009-03-31
Earnings History > 42 > date
2009-03-31
Earnings History > 42 > before After Market
-
Earnings History > 42 > currency
USD
Earnings History > 42 > eps Actual
-0.0316
Earnings History > 42 > eps Estimate
-
Earnings History > 42 > eps Difference
0
Earnings History > 42 > surprise Percent
-
Earnings History > 43 > period
2008-12-31
Earnings History > 43 > report Date
2008-12-31
Earnings History > 43 > date
2008-12-31
Earnings History > 43 > before After Market
-
Earnings History > 43 > currency
USD
Earnings History > 43 > eps Actual
-0.0249
Earnings History > 43 > eps Estimate
-
Earnings History > 43 > eps Difference
0
Earnings History > 43 > surprise Percent
-
Earnings History > 44 > period
2008-09-30
Earnings History > 44 > report Date
2008-09-30
Earnings History > 44 > date
2008-09-30
Earnings History > 44 > before After Market
-
Earnings History > 44 > currency
USD
Earnings History > 44 > eps Actual
-0.0259
Earnings History > 44 > eps Estimate
-
Earnings History > 44 > eps Difference
0
Earnings History > 44 > surprise Percent
-
Earnings History > 45 > period
2008-06-30
Earnings History > 45 > report Date
2008-06-30
Earnings History > 45 > date
2008-06-30
Earnings History > 45 > before After Market
-
Earnings History > 45 > currency
USD
Earnings History > 45 > eps Actual
-0.0291
Earnings History > 45 > eps Estimate
-
Earnings History > 45 > eps Difference
0
Earnings History > 45 > surprise Percent
-
Institute of Biomedical Research Corp. provides biomedical research and analytical services in Montenegro and internationally. Its services include regulatory control of industrial activities and products; scientific surveillance of the living environment; research and development of biomedical products and technologies; regulatory evaluation and certification of biomedical products; fundamental scientific research; and development of new diagnostic methods and experimental medical treatments. The company also researchers and develops new biomedical and food products; provides programs for graduate research studies in biomedical and environmental fields; offers two channel analog NMS, digital muscle stimulator, digital TENS, interferential, elite combination, portable four channel digital, portable ultra sound, and other healthcare devices; and provides photon red light for beauty, electric pain relief products, microcurrent electrical nerve stimulators, and high volt pulsed stimulators. In addition, it develops and commercializes microbicidal agents; disinfectant products; bandages for large burns, hard surface disinfection, microbicidal treatment of fabrics and textile products, insecticides against bed bugs and other textile goods, microbicidal towels, and mouthwash products; Purilair, an appliance that sterilizes compressed air circulating within medical instruments; colloidal silver and electro medical devices; and BioStim INF that is used for edema reduction, pain relief, and total treatment. Further, the company provides quality control, regulatory, healthcare, environmental services, environmental analysis, building decontamination, and environmental protection and management services; and regulatory certifications of new biomedical products. Institute of Biomedical Research Corp. was founded in 2010 and is based in Podgorica, Montenegro with a representative office in Montreal, Canada.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ACraig Dickson: My stock secret weapon - it’s invisible but powers the world - ntnews.com.au
1/20/2026
Craig Dickson: My stock secret weapon - it’s invisible but powers the world ntnews.com.au
Read more →Missile defense base dealing with ‘critical’ disruptions at its dining facility - Task & Purpose
1/11/2026
Missile defense base dealing with ‘critical’ disruptions at its dining facility Task & Purpose
Read more →Showing 2 of 10
(Last Updated 2025-03-31)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Institute of Biomedical Research Corp
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-03-31
EPS Actual
-0.0001
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-03-31)
(Last Updated 2025-03-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-03-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-03-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.